These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26837169)

  • 1. [Effects of triptolide on the expression of androgen receptor in human prostate LNCaP cells and its mechanism of action].
    Liu BD; Feng QQ; Gu X; Lu D; Li W
    Yao Xue Xue Bao; 2015 Oct; 50(10):1246-51. PubMed ID: 26837169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.
    Cinar B; Yeung F; Konaka H; Mayo MW; Freeman MR; Zhau HE; Chung LW
    Biochem J; 2004 Apr; 379(Pt 2):421-31. PubMed ID: 14715080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
    Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH
    Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.
    Ben Jemaa A; Sallami S; Céraline J; Oueslati R
    Cell Biol Int; 2013 May; 37(5):464-70. PubMed ID: 23418075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells.
    Ikezoe T; Chen SS; Yang Y; Heber D; Taguchi H; Koeffler HP
    Int J Oncol; 2003 Nov; 23(5):1461-70. PubMed ID: 14532991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells.
    Yang L; Xie S; Jamaluddin MS; Altuwaijri S; Ni J; Kim E; Chen YT; Hu YC; Wang L; Chuang KH; Wu CT; Chang C
    J Biol Chem; 2005 Sep; 280(39):33558-65. PubMed ID: 16061480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells.
    Hsu JC; Zhang J; Dev A; Wing A; Bjeldanes LF; Firestone GL
    Carcinogenesis; 2005 Nov; 26(11):1896-904. PubMed ID: 15958518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of androgen receptors by NaAsO
    Kim Y; Park SE; Moon JW; Kim BM; Kim HG; Jeong IG; Yoo S; Ahn JB; You D; Pak JH; Kim S; Hwang JJ; Kim CS
    Prostate; 2017 Jul; 77(10):1128-1136. PubMed ID: 28556958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and regulation of androgen receptor in the androgen-independent conversion of prostate cancer cells].
    Wang HF; Liu WJ; Jin J; Zhou LQ; Liang LL; Wang Y; Guo YL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 43(4):490-5. PubMed ID: 21844951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of Androgen Receptor Protein Stability by Triptolide in LNCaP Cells.
    Li W; Liu BD; Liao K; Liu Y; Wan ZJ; Dong YF; Cao QQ; Zhu Q; Gu X
    Medicina (Kaunas); 2018 May; 54(3):. PubMed ID: 30344270
    [No Abstract]   [Full Text] [Related]  

  • 11. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells.
    Kaarbø M; Mikkelsen OL; Malerød L; Qu S; Lobert VH; Akgul G; Halvorsen T; Maelandsmo GM; Saatcioglu F
    Cell Oncol; 2010; 32(1-2):11-27. PubMed ID: 20203370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of compound Chinese traditional medicine PC-SPES II in inhibiting proliferation of human prostate cancer cell LNCaP and on expressions of AR and PSA].
    Zhang BY; Li YF; Lai Y; Li YS; Chen ZJ
    Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):950-6. PubMed ID: 26087562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptolide down-regulates COX-2 expression and PGE2 release by suppressing the activity of NF-κB and MAP kinases in lipopolysaccharide-treated PC12 cells.
    Geng Y; Fang M; Wang J; Yu H; Hu Z; Yew DT; Chen W
    Phytother Res; 2012 Mar; 26(3):337-43. PubMed ID: 21717513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triptolide suppresses interleukin-1beta-induced human beta-defensin-2 mRNA expression through inhibition of transcriptional activation of NF-kappaB in A549 cells.
    Jang BC; Lim KJ; Choi IH; Suh MH; Park JG; Mun KC; Bae JH; Shin DH; Suh SI
    Int J Mol Med; 2007 May; 19(5):757-63. PubMed ID: 17390080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.
    Wang Y; Liu G; Tong D; Parmar H; Hasenmayer D; Yuan W; Zhang D; Jiang J
    Prostate; 2015 Aug; 75(11):1187-96. PubMed ID: 25894097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression.
    Lin DL; Whitney MC; Yao Z; Keller ET
    Clin Cancer Res; 2001 Jun; 7(6):1773-81. PubMed ID: 11410519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression.
    Huang W; He T; Chai C; Yang Y; Zheng Y; Zhou P; Qiao X; Zhang B; Liu Z; Wang J; Shi C; Lei L; Gao K; Li H; Zhong S; Yao L; Huang ME; Lei M
    PLoS One; 2012; 7(5):e37693. PubMed ID: 22666381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells.
    Liu J; Youn H; Yang J; Du N; Liu J; Liu H; Li B
    Prostate; 2011 Sep; 71(12):1276-86. PubMed ID: 21308712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down regulation of PSA by C/EBPalpha is associated with loss of AR expression and inhibition of PSA promoter activity in the LNCaP cell line.
    Yin H; Radomska HS; Tenen DG; Glass J
    BMC Cancer; 2006 Jun; 6():158. PubMed ID: 16774685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor mediated epigenetic regulation of CRISP3 promoter in prostate cancer cells.
    Pathak BR; Breed AA; Deshmukh P; Mahale SD
    J Steroid Biochem Mol Biol; 2018 Jul; 181():20-27. PubMed ID: 29477539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.